Professional Documents
Culture Documents
SWOT Case Study
SWOT Case Study
SWOT Case Study
expertise in developing molecules Expert in technical and know how in vaccine market Global health care leader that discover, develop produces markets innovative therapies History of successful merging strategy Strong financial position Strong brand name
Weaknesses 1. 2. 3. 4. 5. Few drugs in later stages of development Minor player on the generic market Has to extend its retail chemist network Weak on biotechnological segment which is the future and growing segment Poor in economies of scale in OTC
Opportunities 1. 2. 3. 4. Threats 1. 2. 3. 4. Patent expiry in patent market Regulatory authorities permissions in new drugs R & d costs rising In generic, our performance is low Genzyme is a biotechnological lab & specialize in rare genetic disease which are niche markets Genzyme is ready for launch of new drugs that are in final steps of development Genzyme has a good product portfolio Major laboratories are interested in taking over the group